Prelude Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $539K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $997K | Buy |
|
|||||
|
2024
Q3 | $835K | Buy |
|
|||||
|
2024
Q2 | $496K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $493K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $261K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $771K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $280K | Sell |
|
|||||
|
2021
Q1 | $660K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $129K | Buy |
|
|||||
|
2020
Q1 | $94K | Buy |
|
|||||
|
2019
Q4 | – | Hold |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $156K | Buy |
|